Myocardial damage and cardiac arrhythmias after intracranial hemorrhage. A critical review.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000209:etiology*; D001285:Atropine / Q000627:therapeutic use; D001921:Brain / Q000502:physiology; D009202:Cardiomyopathies / Q000209:etiology / Q000517:prevention & control; D002395:Catecholamines / Q000494:pharmacology; D002543:Cerebral Hemorrhage / Q000150:complications* / Q000188:drug therapy; D004558:Electric Stimulation; D004569:Electroencephalography; D006321:Heart / Q000187:drug effects; D006329:Heart Conduction System; D006801:Humans; D007031:Hypothalamus / Q000502:physiology; D009203:Myocardial Infarction / Q000209:etiology; D009206:Myocardium / Q000473:pathology; D009638:Norepinephrine / Q000494:pharmacology; D010275:Parasympathetic Nervous System / Q000503:physiopathology; D011433:Propranolol / Q000627:therapeutic use; D013345:Subarachnoid Hemorrhage / Q000150:complications; D013564:Sympathetic Nervous System / Q000503:physiopathology; D014630:Vagus Nerve / Q000502:physiology
D002395:Catecholamines; D001285:Atropine; D011433:Propranolol; D000109:Acetylcholine; D009638:Norepinephrine